RU2002734C1 - Способ получени в основном оптически чистой 2(S)-стереоизомерной формы производного глутаровой кислоты - Google Patents

Способ получени в основном оптически чистой 2(S)-стереоизомерной формы производного глутаровой кислоты

Info

Publication number: RU2002734C1
Authority: RU; Russia
Prior art keywords: formula; salt; acid; solution; optically pure
Prior art date: 1989-11-16

Application number

SU904831690A

Other languages

English (en)

Russian (ru)

Inventor

Томпсон Барниш Ян

Джеймс Кийт

Original Assignee

Пфайзер Инк. (US)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-16

Filing date

1990-11-15

Publication date

1993-11-15

1990-11-15 Application filed by Пфайзер Инк. (US) filed Critical Пфайзер Инк. (US)

1993-11-15 Application granted granted Critical

1993-11-15 Publication of RU2002734C1 publication Critical patent/RU2002734C1/ru

Links

238000000034 method Methods 0.000 title claims description 16
150000002310 glutaric acid derivatives Chemical class 0.000 title abstract 2
230000015572 biosynthetic process Effects 0.000 title description 8
238000003786 synthesis reaction Methods 0.000 title description 6
150000001875 compounds Chemical class 0.000 claims description 28
150000003839 salts Chemical class 0.000 claims description 23
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
239000002253 acid Substances 0.000 claims description 17
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
230000005595 deprotonation Effects 0.000 claims description 5
238000010537 deprotonation reaction Methods 0.000 claims description 5
230000020477 pH reduction Effects 0.000 claims description 5
239000011541 reaction mixture Substances 0.000 claims description 5
-1 cyclopentanecarboxylic acid lithium diisopropylamide Chemical compound 0.000 claims description 4
239000003960 organic solvent Substances 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 3
125000000217 alkyl group Chemical group 0.000 claims description 2
239000000243 solution Substances 0.000 description 24
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
239000000047 product Substances 0.000 description 17
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
239000002585 base Substances 0.000 description 9
JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 9
UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 9
150000001447 alkali salts Chemical class 0.000 description 7
238000001704 evaporation Methods 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
230000008020 evaporation Effects 0.000 description 6
238000002156 mixing Methods 0.000 description 6
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
238000009903 catalytic hydrogenation reaction Methods 0.000 description 5
239000000203 mixture Substances 0.000 description 5
239000000741 silica gel Substances 0.000 description 5
229910002027 silica gel Inorganic materials 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 4
238000013375 chromatographic separation Methods 0.000 description 4
125000004494 ethyl ester group Chemical group 0.000 description 4
239000000543 intermediate Substances 0.000 description 4
230000003287 optical effect Effects 0.000 description 4
RCCYSVYHULFYHE-UHFFFAOYSA-N pentanediamide Chemical class NC(=O)CCCC(N)=O RCCYSVYHULFYHE-UHFFFAOYSA-N 0.000 description 4
159000000000 sodium salts Chemical class 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
239000003054 catalyst Substances 0.000 description 3
239000010779 crude oil Substances 0.000 description 3
229940043279 diisopropylamine Drugs 0.000 description 3
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
238000010828 elution Methods 0.000 description 3
DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 3
239000003921 oil Substances 0.000 description 3
229910000027 potassium carbonate Inorganic materials 0.000 description 3
235000019260 propionic acid Nutrition 0.000 description 3
239000002904 solvent Substances 0.000 description 3
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
238000005160 1H NMR spectroscopy Methods 0.000 description 2
NOOYFQLPKUQDNE-UHFFFAOYSA-N 2-(bromomethyl)prop-2-enoic acid Chemical compound OC(=O)C(=C)CBr NOOYFQLPKUQDNE-UHFFFAOYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
150000001340 alkali metals Chemical class 0.000 description 2
229910052784 alkaline earth metal Inorganic materials 0.000 description 2
150000001342 alkaline earth metals Chemical class 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
238000011914 asymmetric synthesis Methods 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000001640 fractional crystallisation Methods 0.000 description 2
239000013067 intermediate product Substances 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
150000004702 methyl esters Chemical class 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000012071 phase Substances 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
239000011591 potassium Substances 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
239000007858 starting material Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
125000004846 (C1-C4) allyl group Chemical group 0.000 description 1
BIQQWYDMMXATOL-UHFFFAOYSA-N 1-(3-amino-2-carboxypropyl)cyclopentane-1-carboxylic acid Chemical compound NCC(C(O)=O)CC1(C(O)=O)CCCC1 BIQQWYDMMXATOL-UHFFFAOYSA-N 0.000 description 1
QCHPKSFMDHPSNR-UHFFFAOYSA-N 3-aminoisobutyric acid Chemical compound NCC(C)C(O)=O QCHPKSFMDHPSNR-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
101100179406 Caenorhabditis elegans iff-1 gene Proteins 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
241000120529 Chenuda virus Species 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
229940030600 antihypertensive agent Drugs 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
238000010533 azeotropic distillation Methods 0.000 description 1
229940077388 benzenesulfonate Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
229940050390 benzoate Drugs 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
BZYFSQTXMFJOEB-UHFFFAOYSA-N buta-2,3-dienoic acid Chemical compound OC(=O)C=C=C BZYFSQTXMFJOEB-UHFFFAOYSA-N 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
229940001468 citrate Drugs 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000012259 ether extract Substances 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical class OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
229940076701 hydro 35 Drugs 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
230000003993 interaction Effects 0.000 description 1
150000003951 lactams Chemical class 0.000 description 1
YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
UMELTKSLWXJXNZ-UHFFFAOYSA-N methyl 3,5-dinitrosalicylate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O UMELTKSLWXJXNZ-UHFFFAOYSA-N 0.000 description 1
125000006178 methyl benzyl group Chemical group 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
239000011259 mixed solution Substances 0.000 description 1
150000004682 monohydrates Chemical class 0.000 description 1
OOHAUGDGCWURIT-UHFFFAOYSA-N n,n-dipentylpentan-1-amine Chemical compound CCCCCN(CCCCC)CCCCC OOHAUGDGCWURIT-UHFFFAOYSA-N 0.000 description 1
JSUOCXDSNOVYIQ-UHFFFAOYSA-N n-benzyl-2-phenylpropan-2-amine Chemical compound C=1C=CC=CC=1C(C)(C)NCC1=CC=CC=C1 JSUOCXDSNOVYIQ-UHFFFAOYSA-N 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
229910003445 palladium oxide Inorganic materials 0.000 description 1
JQPTYAILLJKUCY-UHFFFAOYSA-N palladium(ii) oxide Chemical compound [O-2].[Pd+2] JQPTYAILLJKUCY-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
ZMJJCODMIXQWCQ-UHFFFAOYSA-N potassium;di(propan-2-yl)azanide Chemical compound [K+].CC(C)[N-]C(C)C ZMJJCODMIXQWCQ-UHFFFAOYSA-N 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
239000001294 propane Substances 0.000 description 1
235000020185 raw untreated milk Nutrition 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
AEZPDFMFNUKVCF-UHFFFAOYSA-N tert-butyl 2-(bromomethyl)prop-2-enoate Chemical compound CC(C)(C)OC(=O)C(=C)CBr AEZPDFMFNUKVCF-UHFFFAOYSA-N 0.000 description 1
125000005208 trialkylammonium group Chemical group 0.000 description 1
125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
238000007738 vacuum evaporation Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Lubricants (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SU904831690A 1989-11-16 1990-11-15 Способ получени в основном оптически чистой 2(S)-стереоизомерной формы производного глутаровой кислоты RU2002734C1 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898925933A GB8925933D0 (en)	1989-11-16	1989-11-16	Glutaric acid derivatives and preparation thereof

Publications (1)

Publication Number	Publication Date
RU2002734C1 true RU2002734C1 (ru)	1993-11-15

Family

ID=10666416

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SU904831690A RU2002734C1 (ru)	1989-11-16	1990-11-15	Способ получени в основном оптически чистой 2(S)-стереоизомерной формы производного глутаровой кислоты

Country Status (29)

Country	Link
US (1)	US5087732A (pl)
EP (1)	EP0432898B1 (pl)
JP (1)	JPH03176460A (pl)
KR (1)	KR940005958B1 (pl)
CN (2)	CN1028361C (pl)
AT (1)	ATE104270T1 (pl)
AU (1)	AU623814B2 (pl)
BR (1)	BR9005746A (pl)
CA (1)	CA2029785C (pl)
CZ (1)	CZ284374B6 (pl)
DE (1)	DE69008130T2 (pl)
DK (1)	DK0432898T3 (pl)
EG (1)	EG19319A (pl)
ES (1)	ES2062410T3 (pl)
FI (1)	FI107148B (pl)
GB (1)	GB8925933D0 (pl)
HU (1)	HU207711B (pl)
IE (1)	IE63684B1 (pl)
IL (1)	IL96299A (pl)
MX (1)	MX23335A (pl)
MY (1)	MY104782A (pl)
NO (1)	NO179072C (pl)
NZ (1)	NZ236080A (pl)
PH (1)	PH27369A (pl)
PL (2)	PL164543B1 (pl)
PT (1)	PT95889B (pl)
RU (1)	RU2002734C1 (pl)
SK (1)	SK568590A3 (pl)
ZA (1)	ZA909161B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208236A (en) *	1992-09-23	1993-05-04	Schering Corporation	N-(acylaminomethyl)glutaryl amino acids and use
FR2890069B1 (fr) *	2005-08-31	2011-03-04	Senn Chemicals Internat	Intermediaires de synthese pour la preparation de b2-aminoacides et leurs procedes de preparation
EP2380871B1 (en) *	2010-04-15	2013-01-09	Indena S.p.A.	A process for the preparation of isoserine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
KR880007441A (ko) *	1986-12-11	1988-08-27	알렌 제이.스피겔	스피로-치환된 글루타르아미드 이뇨제
GB8820844D0 (en) *	1988-09-05	1988-10-05	Pfizer Ltd	Therapeutic agents

1989
- 1989-11-16 GB GB898925933A patent/GB8925933D0/en active Pending
1990
- 1990-10-26 US US07/604,845 patent/US5087732A/en not_active Expired - Fee Related
- 1990-11-09 IL IL96299A patent/IL96299A/xx active IP Right Grant
- 1990-11-12 EG EG67590A patent/EG19319A/xx active
- 1990-11-13 AT AT90312347T patent/ATE104270T1/de not_active IP Right Cessation
- 1990-11-13 DE DE69008130T patent/DE69008130T2/de not_active Expired - Fee Related
- 1990-11-13 BR BR909005746A patent/BR9005746A/pt not_active Application Discontinuation
- 1990-11-13 ES ES90312347T patent/ES2062410T3/es not_active Expired - Lifetime
- 1990-11-13 DK DK90312347.9T patent/DK0432898T3/da active
- 1990-11-13 CA CA002029785A patent/CA2029785C/en not_active Expired - Fee Related
- 1990-11-13 EP EP90312347A patent/EP0432898B1/en not_active Expired - Lifetime
- 1990-11-14 PT PT95889A patent/PT95889B/pt not_active IP Right Cessation
- 1990-11-14 PL PL90287759A patent/PL164543B1/pl unknown
- 1990-11-14 PL PL90299211A patent/PL164610B1/pl unknown
- 1990-11-14 NZ NZ236080A patent/NZ236080A/en unknown
- 1990-11-14 MX MX2333590A patent/MX23335A/es unknown
- 1990-11-15 FI FI905664A patent/FI107148B/fi not_active IP Right Cessation
- 1990-11-15 RU SU904831690A patent/RU2002734C1/ru active
- 1990-11-15 NO NO904961A patent/NO179072C/no not_active IP Right Cessation
- 1990-11-15 AU AU66684/90A patent/AU623814B2/en not_active Ceased
- 1990-11-15 KR KR1019900018469A patent/KR940005958B1/ko not_active IP Right Cessation
- 1990-11-15 IE IE412190A patent/IE63684B1/en not_active IP Right Cessation
- 1990-11-15 ZA ZA909161A patent/ZA909161B/xx unknown
- 1990-11-16 JP JP2311242A patent/JPH03176460A/ja active Granted
- 1990-11-16 CZ CS905685A patent/CZ284374B6/cs not_active IP Right Cessation
- 1990-11-16 SK SK5685-90A patent/SK568590A3/sk unknown
- 1990-11-16 MY MYPI90002027A patent/MY104782A/en unknown
- 1990-11-16 PH PH41560A patent/PH27369A/en unknown
- 1990-11-16 CN CN90109184A patent/CN1028361C/zh not_active Expired - Fee Related
- 1990-11-16 HU HU907179A patent/HU207711B/hu not_active IP Right Cessation
1994
- 1994-07-07 CN CN94108400A patent/CN1051991C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2062410T3 (es)	1994-12-16
MX23335A (es)	1993-09-01
ATE104270T1 (de)	1994-04-15
IE904121A1 (en)	1991-05-22
KR940005958B1 (ko)	1994-06-25
DE69008130T2 (de)	1994-07-21
PT95889A (pt)	1991-09-13
ZA909161B (en)	1992-06-24
CZ568590A3 (cs)	1998-08-12
PL287759A1 (en)	1991-11-04
CN1051725A (zh)	1991-05-29
FI905664A0 (fi)	1990-11-15
MY104782A (en)	1994-05-31
JPH03176460A (ja)	1991-07-31
PH27369A (en)	1993-06-21
PL164543B1 (pl)	1994-08-31
HUT56536A (en)	1991-09-30
FI905664L (fi)	1991-05-17
EP0432898B1 (en)	1994-04-13
CZ284374B6 (cs)	1998-11-11
AU623814B2 (en)	1992-05-21
CA2029785C (en)	1995-03-28
CN1028361C (zh)	1995-05-10
FI107148B (fi)	2001-06-15
EP0432898A2 (en)	1991-06-19
JPH0585538B2 (pl)	1993-12-07
PL164610B1 (pl)	1994-08-31
NZ236080A (en)	1992-04-28
US5087732A (en)	1992-02-11
NO904961L (no)	1991-05-21
IL96299A (en)	1997-11-20
HU207711B (en)	1993-05-28
CA2029785A1 (en)	1991-05-17
NO904961D0 (no)	1990-11-15
HU907179D0 (en)	1991-05-28
NO179072B (no)	1996-04-22
CN1107135A (zh)	1995-08-23
DE69008130D1 (de)	1994-05-19
IE63684B1 (en)	1995-05-31
DK0432898T3 (da)	1994-05-16
NO179072C (no)	1996-07-31
EG19319A (en)	1994-09-29
AU6668490A (en)	1991-05-23
PT95889B (pt)	1997-06-30
GB8925933D0 (en)	1990-01-04
EP0432898A3 (en)	1991-09-11
BR9005746A (pt)	1991-07-30
SK282272B6 (sk)	2001-12-03
KR910009635A (ko)	1991-06-28
SK568590A3 (en)	2001-12-03
CN1051991C (zh)	2000-05-03
IL96299A0 (en)	1991-08-16

Publication	Publication Date	Title
JP2981747B2 (ja)	1999-11-22	９，１０−エンドエタノー９，１０−ジヒドロアントラセン−１１，１１−ジカルボン酸のモノエステルまたはジエステルの合成方法
WO2006125964A1 (en)	2006-11-30	A process for the dynamic resolution of (substituted) (r) - or (s) -mandelic acid
RU2002734C1 (ru)	1993-11-15	Способ получени в основном оптически чистой 2(S)-стереоизомерной формы производного глутаровой кислоты
JPH05112525A (ja)	1993-05-07	４−ヒドロキシ−２−オキソ−ピロリジン−１−イル−アセトアミドの製造方法
JPS623141B2 (pl)	1987-01-23
US4325877A (en)	1982-04-20	Production of intermediates for enzyme inhibitors
US5260467A (en)	1993-11-09	Glutaric acid derivatives and preparation thereof
EP1501516B1 (en)	2006-06-21	A process for the preparation of benazepril hydrochloride
US5157138A (en)	1992-10-20	Glutaric acid derivatives and preparation thereof
JP4199318B2 (ja)	2008-12-17	キラルで、非ラセミの（４−アリール−２，５−ジオキソイミダゾリジン−１−イル）酢酸の製造方法
CN114790161B (zh)	2023-12-01	4-甲氧基羰基乙基-3-甲基-2-吡咯醛的合成方法及其中间体
JPS61152663A (ja)	1986-07-11	オキセタノン類
JP3132025B2 (ja)	2001-02-05	（−）−ゴニオミチンの製造方法
EP0970952B1 (en)	2006-08-09	Processes for preparing 2-omega-alkoxycarbonylalkanoyl)-4-butanolides, omega-hydroxy-omega-3)-keto fatty esters, and derivatives thereof
SU294330A1 (ru)		Способ получения ы-замещенных 1,2-ди гидрохино- линов или их 5-, 6- или 7-производных
KR910002154B1 (ko)	1991-04-06	3-피롤린 유도체와 그의 제조방법
FR2569194A1 (fr)	1986-02-21	Procede de preparation d'une aminolactone
JP2000239274A (ja)	2000-09-05	新規ナフチリジン誘導体の製造法
JPH0136825B2 (pl)	1989-08-02
JP2002275138A (ja)	2002-09-25	２−アミノインダン誘導体の製造方法およびその中間体
JP2002544190A (ja)	2002-12-24	新規方法
MXPA01011273A (en)	2002-06-05	New process
JPH02250848A (ja)	1990-10-08	シクロオクタン誘導体及びその使用
JPH08165282A (ja)	1996-06-25	２−アルキル−４−オキソ−５、６、７、８−テトラヒドロ−シクロヘプトイミダゾ−ルの製造方法